TiVentures is managed by hands-on entrepreneurs
with international experience in venture-capital funded companies
in the biomedical and high-tech areas
Lorenzo is a serial entrepreneur and founder of several biomedical companies in the US and in Europe.
He has deep experience and extensive network in drug development, academic research, venture capital and strategic innovation.
Lorenzo was the founding managing director of the innovation agency of southern Switzerland (Agire) and started Agire Invest (now TiVentures). He holds a Ph.D. in biochemistry from University of Lausanne and was Assistant Professor at the department of Medicine of UCSD, San Diego, working in immunology and oncology.
Paolo has many years of experience in building, advising and investing in growing technology businesses.
He loves supporting founders as they build and scale their start ups.
Paolo joined Agire Invest (now TiVentures) as Managing Partner in 2011. Prior to that he founded TChip Semiconductors and NemeriX, both active in the development of integrated circuits for satellite navigation. NemeriX was acquired by Qualcomm Inc. in 2009. Paolo also recently founded Oculox
Technologies, a start-up active in the ophthalmology domain. He holds a Ph.D. Degree in Microelectronics from ETH Zurich.
Martina has a strong financial and management
Martina’s unique entrepreneurial attitude and strong communications skills are essential in the operational and strategic activities of TiVenture.
She holds a Master Degree in Management and Finances at Bocconi University (Milan).
The Board of Director adds leadership and expert advice with 360 °
in growing highly successful companies
TiVenture was born in 2016 from Agire Invest, the “investment arm” of the Fondazione Agire, the Innovation Agency of Ticino Canton that started investing in early innovative companies in 2012. Dr. Lorenzo Leoni was the founding CEO of Agire and Dr. Paolo Orsatti managed its investment activities. During the next 4 years, they invested in more than 15
early-stage companies and expanded the network of private and institutional co-investors that supported the growth
of the companies.
Due to the success of these activities and to allow further expansion, in 2016 the Cantonal Bank of Ticino (BancaStato, www.bancastato.ch) created the Fondazione del Centenario and acquired 100% of Afire Invest changing the name into TiVenture. Since 2016 TiVenture operates as an independent early-stage technology investor, investing in Ticino-based companies, and collaborating with Agire, the State Government, the local Universities and contributing to the growth, diversification and innovation of the economy in the Ticino territory.
Today, TiVenture represents a success story: its companies are rapidly growing, with aggregate revenues exceeding CHF 17 Mio and a total number of employees exceeding 160 and demonstrate very well the potential for economic innovation of Ticino.
Seed investment in Gain Therapeutics
Succesfull exit from Sailogy
Partial Exit 4BASES
Series A round Gain Therapeutics SA
Series A round DAC System
Series A round Xfarm with United Ventures
IBI SA obtains European Approval for SmartBONE
Overall revenues for portfolio companies >CHF10Mio
Total number of employees in companies >100
Succesfull exit from 99 Technologies SA
Series B round Gain Therapeutics US investors
Series A round Delvitech with Helvetica Partners
Series A round Artificialy
Total number of employees in companies >150
Overall revenues for portfolio companies >CHF 17Mio
Seed investment BigOmics Analytics
IPO Gain Therapeutics (GANX) at NASDAQ GLOBAL
Experienced and succesful
Hands-on coaching and
Specialized in early stage
Swiss precision and
Discover our latest news
When precision makes a Difference. Swiss Company specialized in the research, development, production and commercialization of clinically validated and certified genetic diagnostic solutions.
99 Technologies engineers and manufactures innovative and highly effective disinfection solutions for hospitals and other areas. Exited.
Delivering Intelligence. Artificial Intelligence actually delivered.
Self-Service Bioinformatics. World’s first self-service platform for visual analytics of Big Omics data. Analyze your data 10 times faster, 100 times smarter.
Excellence in Hospitality. Digital hospitality management platform to visibly improve the day-to-day tasks. Happy Guests – Happy Staff.
Smart Antenna Monitoring Systems. DAC System develop and commercializes innovative monitoring systems for broadcasters to reduce costs and repair time.
Leaders in Automated Optical Inspections Systems. Delvitech designs, manufactures and delivers intelligent solutions for AOI Automated Optical Inspection for the electronics industry.
Enabling Digital Agriculture with Real Impact. A pioneer in digital agriculture, an online solution to provide farmers easy access to real-time information about their crops and how to best manage them.
3D Printing for Glass Microdevices. High-tech company designing and manufacturing 3D Glass Microdevices with high precision and quality.
Unfolding New Therapies for rare and Genetic and Neurodegenerative Diseases. Biotechnology using powerful and proprietary computational data algorithms to discover and develop small molecules for genetic diseases.
The Next Frontier of Bone Regeneration. focused on research, development, production and commercialization of medical devices for tissue engineering and regenerative medicine.
Disrupting the training experience of students and professionals worldwide. Designing life-like simulations empowering crucial behavioral skills and enhancing learning experiences.
Sailing Holidays Worldwide. Online booking platform for making sailing holidays accessible to everyone. Exited.
Discover and Book any entertainers. Online booking platform where you can discover and book any kind of entertainers.
Simple and complete digital platform for digital farming, created by farmers for farmers.